Literature DB >> 10598627

Exposure to cigarette smoke impairs alveolar macrophage functions during halothane and isoflurane anesthesia in rats.

N Kotani1, H Hashimoto, D I Sessler, Y Yatsu, M Muraoka, A Matsuki.   

Abstract

BACKGROUND: Smoking alters numerous alveolar macrophage functions and is an important risk factor for postoperative pulmonary complications. The authors therefore tested the hypothesis that smoke exposure impairs antimicrobial and proinflammatory responses in alveolar macrophages during halothane and isoflurane anesthesia with mechanical ventilation.
METHODS: Thirty control rats and 30 rats exposed to cigarette smoke were mechanically ventilated with 1.5 minimum alveolar concentration halothane and isoflurane. Ten smoke-exposed and control animals were assigned to one of three different anesthetic durations (0, 2, and 6 h). The fraction of aggregated cells and cell distribution were determined. Opsonized and unopsonized phagocytosis was measured. Microbicidal activity was determined as the ability to kill Listeria monocytogenes. The expression of interleukin (IL)-1alpha, IL-1beta, IL-6, macrophage inflammatory protein-2, interferon-gamma, and tumor necrosis factor-alpha was measured by semiquantitative reverse-transcription polymerase chain reaction. Pulmonary lavage concentrations of these cytokines were measured by enzyme-linked immunosorbent assay.
RESULTS: During both halothane and isoflurane anesthesia, the fraction of aggregated macrophages increased, whereas unopsonized and opsonized phagocytosis and microbicidal activity decreased significantly over time in both groups. Responses observed in smoke-exposed rats were almost twice as great as those observed in the control rats. Gene expression and production of all proinflammatory cytokines except IL-6 increased 2-20-fold during anesthesia. The increases in IL-1beta, interferon-gamma, and tumor necrosis factor-alpha in the control rats were 1.5-8 times greater than those in the smoke-exposed rats.
CONCLUSION: Antimicrobial and proinflammatory responses of alveolar macrophages during anesthesia were markedly suppressed by smoke exposure. Our data suggest that smoke exposure reduces the efficacy of immune defenses during anesthesia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598627     DOI: 10.1097/00000542-199912000-00037

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  [Preoperative abstinence from smoking. An outdated dogma in anaesthesia?].

Authors:  B Zwissler; A Reither
Journal:  Anaesthesist       Date:  2005-06       Impact factor: 1.041

2.  Prognostic factors of patients with small cell lung cancer after surgical treatment.

Authors:  Cheng Zeng; Nana Li; Feng Li; Peng Zhang; Kai Wu; Donglei Liu; Song Zhao
Journal:  Ann Transl Med       Date:  2021-07

Review 3.  Tobacco control for anesthesiologists.

Authors:  David O Warner
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

4.  Desflurane inhalation before ischemia increases ischemia-reperfusion-induced vascular leakage in isolated rabbit lungs.

Authors:  Yoshiaki Oshima; Seiji Sakamoto; Kazumasa Yamasaki; Shinsuke Mochida; Kazumi Funaki; Naoki Moriyama; Akihiro Otsuki; Ryo Endo; Masato Nakasone; Shunsaku Takahashi; Tomomi Harada; Yukari Minami; Yoshimi Inagaki
Journal:  Springerplus       Date:  2016-11-29

5.  Impact of smoking history on postoperative complications after lung cancer surgery - a study based on 286 cases.

Authors:  Mateusz Kozub; Bartosz Gachewicz; Mariusz Kasprzyk; Magdalena Roszak; Lukasz Gasiorowski; Wojciech Dyszkiewicz
Journal:  Kardiochir Torakochirurgia Pol       Date:  2019-04-04

6.  Blunt Chest Trauma in Mice after Cigarette Smoke-Exposure: Effects of Mechanical Ventilation with 100% O2.

Authors:  Katja Wagner; Michael Gröger; Oscar McCook; Angelika Scheuerle; Pierre Asfar; Bettina Stahl; Markus Huber-Lang; Anita Ignatius; Birgit Jung; Matthias Duechs; Peter Möller; Michael Georgieff; Enrico Calzia; Peter Radermacher; Florian Wagner
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.